share_log

Spyre Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Fairmount Funds Management LLC

SEC ·  Apr 25 17:01
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more